ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,675.68
1.18%
Gold vs US Dollar
2,302.57
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,556.39
1.06%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aptorum Group Ltd (APM)

  7. Aptorum Group Ltd (APM) News

Aptorum (APM)

Aptorum Group Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:APM
DateTimeSourceHeadlineSymbolCompany
30/04/202414:15Business WireAptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business UpdateNASDAQ:APMAptorum Group Ltd
06/03/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
06/03/202413:00Business WireAptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy BusinessNASDAQ:APMAptorum Group Ltd
22/12/202321:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
22/12/202321:30Business WireAptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023NASDAQ:APMAptorum Group Ltd
21/12/202321:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
21/12/202321:30Business WireAptorum Group Limited Announces Results of 2023 Annual General Meeting of ShareholdersNASDAQ:APMAptorum Group Ltd
30/11/202321:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
21/11/202315:25Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:APMAptorum Group Ltd
16/11/202316:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
16/11/202316:00Business WireAptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023NASDAQ:APMAptorum Group Ltd
11/09/202321:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
10/08/202311:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
10/08/202307:57Business WireAptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital MarketsNASDAQ:APMAptorum Group Ltd
14/07/202321:30Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:APMAptorum Group Ltd
30/06/202321:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
30/06/202321:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
22/06/202313:00Business WireAptorum Group Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for NeuroblastomaNASDAQ:APMAptorum Group Ltd
09/06/202321:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APMAptorum Group Ltd
09/06/202321:30Business WireAptorum Group Limited Announces Voluntary Delisting from Euronext ParisNASDAQ:APMAptorum Group Ltd
24/05/202314:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APMAptorum Group Ltd
22/05/202311:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APMAptorum Group Ltd
17/05/202321:31Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:APMAptorum Group Ltd
08/05/202314:00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APMAptorum Group Ltd
05/05/202321:31Business WireAptorum Group Receives Nasdaq Notification of Minimum Stockholders’ Equity DeficiencyNASDAQ:APMAptorum Group Ltd
03/05/202314:29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APMAptorum Group Ltd
01/05/202313:00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APMAptorum Group Ltd
01/05/202313:00Business WireAptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group’s Subsidiary Paths Innovations LimitedNASDAQ:APMAptorum Group Ltd
28/04/202314:44Business WireAptorum Group Limited Reports 2022 Fiscal Year End Financial Results and Provides Business UpdateNASDAQ:APMAptorum Group Ltd
28/04/202314:19Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APMAptorum Group Ltd
 Showing the most relevant articles for your search:NASDAQ:APM

Your Recent History

LSE
SCLP
Scancell
LSE
AGL
Angle
LSE
SCE
Surface Transforms
LSE
EEE
Empire Metals
LSE
FUM
Futura Medical
LSE
SRSP
Sirius Petroleum
LSE
MIN
Minoan
LSE
TERN
Tern
LSE
GFM
Griffin Mining
LSE
AAU
Ariana Resources
LSE
JAY
Bluejay Mining
LSE
ENET
Ethernity Networks
LSE
GKP
Gulf Keystone Petroleum
LSE
TRIN
Trinity Exploration & Pr...
LSE
GOLD
LSE
PHNX
Phoenix
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved